Ticker: TSHA

Taysha Gene Therapies, Inc. (TSHA on NASDAQ) Quick summary - what's happening inside Taysha raised a large equity tranche in May 2025 and entered a refinanced term‑loan in August 2025, materially improving near‑term liquidity while continuing to spend heavily on its lead gene‑therapy program TSHA...

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) has reported its quarterly performance for the period ending March 31, 2025. This analysis will highlight both the positive and negative aspects of the company's income statement. Key Points and Statistics: Revenue: $2.3 million (down from $3.4 million ...